Oura’s Ricky Bloomfield, Gyde’s Will Johnson, Parkinson’s Cell Therapy, Blue Cross Sued
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
Can a ring become care, and why does America have a million insurance brokers?
This week on HCN, Cedric Kovacs-Johnson and Danish Nagda dig into Aspen Neuroscience's IPO filing on stem cell therapy for Parkinson's, Michigan's antitrust suit against Blue Cross Blue Shield of Michigan, and HHS's case against the 340B drug discount program. Dr. Ricky Bloomfield, Chief Medical Officer of Oura, joins to talk about turning a consumer wearable into a tool for care. Will Johnson, CEO & Co-Founder…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.